{"id":"https://openalex.org/W2002608782","doi":"https://doi.org/10.1615/critrevimmunol.v18.i1-2.30","title":"Identification of Peptides for Immunotherapy of Cancer. It is Still Worth the Effort","display_name":"Identification of Peptides for Immunotherapy of Cancer. It is Still Worth the Effort","alternate_titles":[],"publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W2002608782","doi":"https://doi.org/10.1615/critrevimmunol.v18.i1-2.30","mag":"2002608782","pmid":"https://pubmed.ncbi.nlm.nih.gov/9419444"},"language":"en","primary_location":{"id":"doi:10.1615/critrevimmunol.v18.i1-2.30","doi":"https://doi.org/10.1615/critrevimmunol.v18.i1-2.30","is_oa":false,"landing_page_url":"https://doi.org/10.1615/critrevimmunol.v18.i1-2.30","pdf_url":null,"source":{"id":"https://openalex.org/S73794665","display_name":"Critical Reviews in Immunology","issn_l":"0197-3355","issn":["0197-3355","1040-8401","2162-6472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315730","host_organization_name":"Begell House","host_organization_lineage":["https://openalex.org/P4310315730"],"host_organization_lineage_names":["Begell House"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews\u2122 in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002608782"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108228650","display_name":"Markwin P. Velders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Markwin P. Velders","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University, Chicago, Maywood, IL 60153, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University, Chicago, Maywood, IL 60153, USA","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087934172","display_name":"John D. Nieland","orcid":"https://orcid.org/0000-0001-7423-0122","observed_orcids":["https://orcid.org/0000-0001-7423-0122"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John D. Nieland","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","Department of Health Science and Technology, The Faculty of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"Department of Health Science and Technology, The Faculty of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041401757","display_name":"Michael P. Rudolf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael P. Rudolf","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033440873","display_name":"Kathleen Loviscek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kathleen Loviscek","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088028026","display_name":"Sanne Weijzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sanne Weijzen","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108203131","display_name":"Earin E. de Visser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Earin E. de Visser","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021782091","display_name":"M. F\u00e1tima Macedo","orcid":"https://orcid.org/0000-0002-2252-6105","observed_orcids":["https://orcid.org/0000-0002-2252-6105"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Fatima Macedo","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051401259","display_name":"Michele Carbone","orcid":"https://orcid.org/0000-0001-8928-8474","observed_orcids":["https://orcid.org/0000-0001-8928-8474"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michele Carbone","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048611754","display_name":"W. Martin Kast","orcid":"https://orcid.org/0000-0003-2321-3159","observed_orcids":["https://orcid.org/0000-0003-2321-3159"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Martin Kast","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1925986"],"apc_list":null,"apc_paid":null,"fwci":1.3434,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.79510765,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"1-2","first_page":"7","last_page":"27"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunogenic-peptides","display_name":"immunogenic peptides","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/peptide-based-vaccination","display_name":"peptide-based vaccination","score":0.5609999895095825},{"id":"https://openalex.org/keywords/t-cell-receptor-recognition","display_name":"T cell receptor recognition","score":0.8830000162124634},{"id":"https://openalex.org/keywords/t-cell-mediated-immunity","display_name":"T cell immunity","score":0.7680000066757202},{"id":"https://openalex.org/keywords/peptide-identification","display_name":"peptide identification","score":0.6209999918937683},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.7929999828338623},{"id":"https://openalex.org/keywords/allergy","display_name":"allergy","score":0.4449999928474426},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.8539999723434448},{"id":"https://openalex.org/keywords/peptide-motifs","display_name":"peptide motifs","score":0.7059999704360962}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7254028916358948},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6776486039161682},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.6460806131362915},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6359875798225403},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4925611615180969},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4891648590564728},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.4449988305568695},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4289413094520569},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4017733037471771},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3587072789669037},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34868043661117554},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11331915855407715},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1615/critrevimmunol.v18.i1-2.30","doi":"https://doi.org/10.1615/critrevimmunol.v18.i1-2.30","is_oa":false,"landing_page_url":"https://doi.org/10.1615/critrevimmunol.v18.i1-2.30","pdf_url":null,"source":{"id":"https://openalex.org/S73794665","display_name":"Critical Reviews in Immunology","issn_l":"0197-3355","issn":["0197-3355","1040-8401","2162-6472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315730","host_organization_name":"Begell House","host_organization_lineage":["https://openalex.org/P4310315730"],"host_organization_lineage_names":["Begell House"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews\u2122 in Immunology","raw_type":"journal-article"},{"id":"pmid:9419444","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9419444","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in immunology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2331587373","display_name":"HPV AND ANTIGEN PRESENTING CELLS","funder_award_id":"R01CA074397","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2969383918","display_name":null,"funder_award_id":"R29 CA74283","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W33774928","https://openalex.org/W1987419864","https://openalex.org/W3202270340","https://openalex.org/W2104401164","https://openalex.org/W4225333487","https://openalex.org/W4407278105","https://openalex.org/W2773420643","https://openalex.org/W2994042846","https://openalex.org/W1562729285"],"abstract_inverted_index":{"As":[0],"the":[1,4,24,35,49,58,79,91,114,117,122,129,137],"nature":[2],"of":[3,16,26,48,60,69,96,125,139,160],"T":[5,12],"cell":[6,13],"immune":[7,37,50],"response":[8],"is":[9],"defined":[10],"by":[11],"receptor":[14],"recognition":[15],"small":[17],"protein":[18],"fragments,":[19],"referred":[20],"to":[21,31,65,67,112],"as":[22,146,148],"peptides,":[23,140],"identification":[25,98,138],"peptides":[27,40,62,83,170],"would":[28],"lead":[29,66],"us":[30],"understanding":[32],"and":[33,46,54,72,88,99,103,120,158,165],"directing":[34],"T-cell-mediated":[36],"response.":[38],"Immunogenic":[39],"might":[41],"be":[42,108],"used":[43],"for":[44,81,128,169],"vaccination":[45],"activation":[47],"reaction":[51],"against":[52],"cancer-":[53],"virus-infected":[55],"cells.":[56],"Additionally,":[57],"knowledge":[59,127],"immunogenic":[61,82],"was":[63,84],"expected":[64],"blocking":[68],"allergic":[70],"reactions":[71],"autoimmune":[73],"diseases.":[74],"Based":[75],"on":[76],"these":[77],"assumptions,":[78],"search":[80],"started":[85],"in":[86,90,101,104,143,163,174],"mice":[87],"man":[89],"mid-1980s.":[92],"After":[93],"a":[94,109],"decade":[95],"peptide":[97,152,161,172],"testing":[100],"vitro":[102],"vivo,":[105],"this":[106,126,133],"may":[107],"proper":[110],"time":[111],"evaluate":[113],"results":[115],"from":[116,151],"peptide-related":[118],"work":[119],"determine":[121],"possible":[123,167],"applications":[124,168],"next":[130],"decade.":[131],"In":[132],"review":[134],"we":[135],"discuss":[136],"their":[141],"use":[142,162],"murine":[144],"models,":[145],"well":[147],"clinical":[149],"data":[150],"vaccinations":[153],"or":[154,171],"therapies.":[155],"Potential":[156],"hazards":[157],"limitations":[159],"immunotherapy":[164,175],"other":[166],"motifs":[173],"are":[176],"evaluated.":[177]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002608782","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
